Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAXIMIZA renal transplant maintenance study
2009-014562-26Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate sodium, mycophenolate mofetil and tacrolimus in kidney transplant immunosuppression (2 arms), sponsored by Novartis. Started Dec 2009; status: completed.
02
Drugs
mycophenolate sodiummycophenolate mofetiltacrolimus
03
Conditions
kidney transplant immunosuppression
Beyond the preview
Go deeper on 2009-014562-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014562-26.